Literature DB >> 642407

Interference of spironolactone therapy with adrenal steroid metabolism in secondary hyperaldosteronism.

U Abshagen, S Spörl, M Schöneshöfer, M L'age, W Oelkers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 642407     DOI： 10.1007/BF01477394

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN： 0023-2173


× No keyword cloud information.
  31 in total

1.  Interference by spironolactone of radioassays for progesterone and estrogen.

Authors:  E V YoungLai; S L Smith; E Choy
Journal:  Horm Metab Res       Date:  1975-07       Impact factor: 2.936

2.  [Spironolactone and thiabutazide in the treatment of essential hypertension (author's transl)].

Authors:  F Klump; B Braun; D Klaus; R Lemke; J Zehner; P Zöfel
Journal:  Dtsch Med Wochenschr       Date:  1975-03-21       Impact factor: 0.628

3.  Blocking the renal electrolyte effects of mineralocorticoids with an orally active steroidal spirolactone.

Authors:  C M KAGAWA
Journal:  Endocrinology       Date:  1960-07       Impact factor: 4.736

4.  The effect of angiotensin II infusion on plasma corticosteroid concentrations in normal man.

Authors:  P A Mason; R Fraser; J J Morton; P F Semple; A Wilson
Journal:  J Steroid Biochem       Date:  1976-10       Impact factor: 4.292

5.  Spironolactone metabolism in man studied by gas chromatography-mass spectrometry.

Authors:  A Karim; J Hribar; W Aksamit; M Doherty; L J Chinn
Journal:  Drug Metab Dispos       Date:  1975 Nov-Dec       Impact factor: 3.922

6.  Reduced aldosterone secretion during spironolactone treatment in primary aldosteronism: report of a case.

Authors:  J A Sundsfjord; P Marton; H Jorgensen; A Aakvaag
Journal:  J Clin Endocrinol Metab       Date:  1974-10       Impact factor: 5.958

7.  Radioimmunoassay of free aldosterone and of its 18-oxo-glucuronide in human urine.

Authors:  P Vecsei; B Penke; A Joumaah
Journal:  Experientia       Date:  1972-05-15

8.  [Secretion, plasma concentration, distribution, metabolism and excretion of aldosterone in healthy and sick subjects].

Authors:  D Lommer; G Düsterdieck; J Jahnecke; P Vecsei; H P Wolff
Journal:  Klin Wochenschr       Date:  1968-07-15

9.  Chemical structure and aldosterone receptor affinity of canrenoate-potassium metabolites in rabbits.

Authors:  A M Finn; C Finn; W Sadée
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1976-12

10.  Mechanism of action of spironolactone on adrenocortical function in guinea pigs.

Authors:  J W Greiner; R E Kramer; J Jarrell; H D Colby
Journal:  J Pharmacol Exp Ther       Date:  1976-09       Impact factor: 4.030
View more
  3 in total

1.  Distal tubular segments of the rabbit kidney after adaptation to altered Na- and K-intake. I. Structural changes.

Authors:  B Kaissling; M Le Hir
Journal:  Cell Tissue Res       Date:  1982       Impact factor: 5.249

2.  Influence of spironolactone on serum corticosteroids in primary hyperaldosteronism.

Authors:  U Abshagen; S Spörl; W Oelkers
Journal:  Klin Wochenschr       Date:  1979-02-15

3.  Metabolic effects of high dose amiloride and spironolactone: a comparative study in normal subjects.

Authors:  J A Millar; R Fraser; P Mason; B Leckie; A M Cumming; J I Robertson
Journal:  Br J Clin Pharmacol       Date:  1984-09       Impact factor: 4.335
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.